Pill form of semaglutide may be a suitable option for adults with overweight or obesity, trial suggestsPill form of semaglutide may be a suitable option for adults with overweight or obesity, trial suggests
A Novo Nordisk designed trial reports that their 25 mg oral semaglutide taken once daily produced greater mean weight reduction than placebo over 64 weeks in adults with overweight or obesity. A Novo Nordisk designed trial reports that their 25 mg oral semaglutide taken once daily produced greater mean weight reduction than placebo over 64 Read More
GLP-1 Drugs Look Good for Psoriasis, Not So Much for HairGLP-1 Drugs Look Good for Psoriasis, Not So Much for Hair
(MedPage Today) — GLP-1 agonists appeared to have a bigger impact on the physical and mental health of patients with psoriasis compared with other patients, a large retrospective cohort study showed. Reductions in overall mortality, major adverse… (MedPage Today) — GLP-1 agonists appeared to have a bigger impact on the physical and mental health Read More
Novo Nordisk study finds greater waist reduction with higher semaglutide dosageNovo Nordisk study finds greater waist reduction with higher semaglutide dosage
A Novo Nordisk-designed trial, conducted at 68 international hospitals, specialist clinics, and medical centers with investigators from University of Texas Southwestern Medical Center and other institutions, reports greater reductions with once-weekly semaglutide 7.2 mg than placebo in bodyweight, waist circumference, and HbA1c over 72 weeks. A Novo Nordisk-designed trial, conducted at 68 international hospitals, specialist Read More
People on Ozempic who eat to regulate emotions less likely to lose weight, research revealsPeople on Ozempic who eat to regulate emotions less likely to lose weight, research reveals
GLP-1 receptor agonists like Ozempic can be a lifeline for people with diabetes—helping stabilize blood glucose and lose weight, which contributes to diabetes complications. But not everyone benefits equally. GLP-1 receptor agonists like Ozempic can be a lifeline for people with diabetes—helping stabilize blood glucose and lose weight, which contributes to diabetes complications. But not Read More
Ozempic, Wegovy and Mounjaro makes food taste sweeter and saltier, and that may quiet cravingsOzempic, Wegovy and Mounjaro makes food taste sweeter and saltier, and that may quiet cravings
Some people taking Ozempic, Wegovy, or Mounjaro notice that food suddenly tastes sweeter or saltier, and this subtle shift in flavor perception appears tied to reduced appetite and stronger feelings of fullness. In a study of more than 400 patients, roughly one in five experienced heightened taste sensitivity, and many reported being less hungry and Read More
Ozempic, Wegovy and Mounjaro makes food taste sweeter and saltier, and that may quiet cravingsOzempic, Wegovy and Mounjaro makes food taste sweeter and saltier, and that may quiet cravings
Some people taking Ozempic, Wegovy, or Mounjaro notice that food suddenly tastes sweeter or saltier, and this subtle shift in flavor perception appears tied to reduced appetite and stronger feelings of fullness. In a study of more than 400 patients, roughly one in five experienced heightened taste sensitivity, and many reported being less hungry and […]
Bariatric surgery for weight loss shows greater long-term benefits than GLP-1 medicinesBariatric surgery for weight loss shows greater long-term benefits than GLP-1 medicines
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone. A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss Read More
About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than beforeAbout one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) shows that some individuals who are taking Ozempic, Wegovy or Mounjaro find that foods taste sweeter or saltier than before. New research being presented at the Annual Meeting of the European Association Read More
Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirmHigher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm
A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with obesity, including those with type 2 diabetes (T2D), according to the results of two large-scale, international phase 3 clinical trials. A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and Read More
Weight-loss drug semaglutide shown to reduce cocaine use in ratsWeight-loss drug semaglutide shown to reduce cocaine use in rats
Scientists have found that the diabetes/weight loss drug semaglutide, sold commercially under brand names like Ozempic and Wegovy, significantly reduces cocaine-seeking behavior in rats. This work needs to be confirmed in humans, but it suggests that semaglutide is a candidate to be developed as a treatment for cocaine dependency; at the moment there is no Read More